Tetraeder
Volume 57, booklet 46,
12. november 2001
, side 9347-9377
Author links open the overlay panel, , , ,
Stylized lipopeptide compound: (shows the presence of an amino acid group and a fatty acid chain and is thus both hydrophilic and hydrophobic to some extent, in additionLipopeptidercan be defined as compounds that areN-methylated and are thuswater insoluble, for example didemnin B).

introduction
Current trends in drug discovery from natural sources emphasize the study of the marine environment to extract numerous, often highly complex, chemical compounds. is instrumental in the biosynthesis of marine natural products isolated from macroorganisms such as invertebrates.4, 5. In particular, culturable marine microorganisms, especially actinomycetes and fungi, are known to produce bioactive metabolites.6Cyanobacteria (blue-green algae) are also considered to be one of the most promising groups of organisms for the isolation of new, biochemically active natural products. 7., 8., 9., 10.
Historically, screening of crude extracts has proven to be an effective method for identifying organisms that produce potentially beneficial compounds. Early studies focused on land plants and microorganisms proved extremely fruitful and yielded many useful organic compounds such as aspirin,®Penicillin®and taxol.®In the early 1960s, scientists began to look at the oceans as a new and untapped source of potentially useful compounds - perhaps not surprising given that more than 70% of the Earth's surface is water and that the oceans more than 95% of the biosphere turns off. . Of the 27 different strains of life, only 17 are found on land, but all are present in the oceans. With between 1 and 10% of all marine microbes (including cyanobacteria) culturable using current techniques, the marine environment is one of the last regions of great diversity in the world that has yet to be fully explored. In 1975 there were already three parallel lines of research in the chemistry of marine natural products: marine toxins, marine bioproducts and marine chemical ecology. To date, marine natural product chemists have determined the chemical structures of over 13,000 new compounds, and with about half of all cancer drug discovery efforts focused on marine organisms, the outlook for the future looks bright.11
The medicinal properties of cyanobacteria were first recognized in the 16th centuryv. Chr, ifNostocSpecies have been used to treat rheumatism, fistula and various forms of cancer.12However, prior to the 1990s, only limited studies were conducted on the isolation of biologically active natural products from cyanobacteria. In the 1990s, workers worked in several laboratories, including Richard Moore's9(University of Hawaii), William Gerwick13(Oregon State University) and colleagues had begun to study extracts of cyanobacteria, mainly strains ofMicrocystisAndAnabaenasp., for various biological activities, predominantly using mechanism- and enzyme-based assays. 14, 15. Currently, published data indicate that these groups have screened over 4000 strains of freshwater and marine cyanobacteria. The very high abundance of novel biologically active compounds isolated by these investigators to date (6% with anticancer (antiproliferative) activity)15points out that cyanobacteria are a rich source of potentially useful natural products.
It is impossible to completely separate freshwater and marine cyanobacteria and focus exclusively on marine cyanobacteria, as the same species can grow in both environments and produce similar or different natural products.9Therefore, this review reports on cyanobacteria present in the MarinLit reference database.16By definition, it focuses on marine-derived natural products found in the literature.
sectional cuts
havtoksiner
Blooms of freshwater cyanobacteria associated with poisoning in humans and livestock have been extensively studied. 155., 156. Floral taxa, members of the orders Nostocales and Chroococcales (Table 1), includingAnabaena,Aphanizomenon,MicrocystisAndNodulariaSpecies exhibit severe neuro-, cyto-, and hepatotoxicity to a wide variety of mammals (including humans), birds, livestock, fish, and invertebrates (including zooplankton). 155, 157. Marine cyanobacteria are also increasing.
marine organic products
Until recently, toxic agents dominated the spectrum of isolated biological activities, although ecology suggests that antimicrobials and antivirals are the most likely compounds that could be isolated from cyanobacteria.176This may be due in part to the use of cytotoxicity-driven screening assays, which are part of several of the International Cancer Institute's comprehensive natural product discovery programs. Fig. 1, modified from Jaspars et al.177vise
Exciting discoveries from marine cyanobacteria
Although terrestrial cyanobacteria are a recognized source of biologically active, structurally unique natural products, 7. 8. 15. marine species have received significantly less attention.9Perhaps the most significant new discoveries have been the discoveries of borophycin13, Cryptophycin 114and 815and cyanovirine16. Borophycin13is a boron-containing metabolite isolated from marine strains of cyanobacteriaNostoc linckiaAndWe are spongyWar.Outfit.6., 181. Borophycin,
Chemical marine ecology
Although there is an ever-growing body of research on the chemistry and biochemistry of marine toxins and potential drug candidates, as discussed in 3 Marine Bioproducts, 4 Exciting Discoveries From Marine Cyanobacteria, there is little experimental evidence showing the full ecological importance of most cyanobacteria metabolites .158., 184., 185. The authors believe that there is a need for a better understanding of existing ecological contexts and interactions, especially in the sea.
Secondary metabolic pathways
In the last 50 years, microbial products (e.g. pigments, alkaloids, toxins, antibiotics, carotenoids, lipopeptides, etc.) have been isolated and identified that have no obvious function in the life of the organisms that produce them (so-called secondary metabolites). ). their structures illuminated. In the marine microbial world, cyanobacteria are particularly prolific producers of such compounds, many of which exhibit biological activities such as B. antibiotic, anticancer, anti-HIV and toxic activities.
Mens
intensification of bioprocesses
Recent estimates suggest that among the newly approved drugs notified to date, drugs of natural origin (classified as original natural products, semi-synthetic products derived from natural products or synthetic products based on natural product models) predominate.3In some cases the need can be met by total synthesis of the active metabolite, but in many cases this is not a viable option as the synthesis may involve many steps, be relatively expensive and generally produce only small amounts
Lipopeptider
An analysis of the literature on natural products from marine cyanobacteria16shows that about 68% contains nitrogen (ie probably derived from amino acid metabolism). The natural products of many marine cyanobacteria contain an amino acid-derived fragment attached to a fatty acid-derived moiety to form compounds known as lipopeptides72. Further analysis of the 424 marine cyanobacteria natural products included in the MarinLit database shows that 40.2% are lipopeptides
Lyngbya majuscula(Microcoleus lyngbyaceus)
Members of the Oscillatoriaceae, especially the filamentous cyanobacteria,L. Capital lettersGomont, known botanically asM. lyngbyaceushas proven to be a rich source of new and biologically active compounds (Fig. 8). Since 1984, when Carter et al.232Although a wealth of unique secondary metabolites of this cyanobacterium have been reported, the number of reported new compounds of cyanobacterial origin continues to increase dramatically. To date, about 30% of all natural products have been isolated
New research opportunities in this area
Several secondary metabolites isolated fromL. Capital lettersand other cyanobacteria have synergistic activity, ie. H. when similar compounds isolated from the same species or strain of cyanobacteria are combined and analyzed for activity, the sum of the activities of the combined extract is greater than its individual activities. Laxaphycin A77and B78, for example first isolated from the terrestrial cyanobacteria,Anabaena laxa,267., 268. and later also found
Conclusions
Recent studies have shown that marine cyanobacteria have the ability to produce secondary metabolites that are different from other terrestrial species. The chemistry of marine natural products with cyanobacteria, as a new research area, relies heavily on experimental methods developed for terrestrial microorganisms. Although this approach provides a good starting point for investigation, further application of methods for isolation, cultivation and chemical analysis of
so
The authors acknowledge the interdisciplinary doctoral research at Heriot-Watt University and the French government's scientific grant programs for financial support. P.C.W thanks the EPSRC for providing an Advanced Research Fellowship (GR/A11311/01). This review is supported by a grant from the Scottish Hospital Endowments Research Trust (RG 9/99). The authors thank Richard Webb of the University of Queensland, Queensland, Australia for his help with light and electron microscopy, and Carsten
Adam M. Burjareceived his Bachelor of Science from the University of Melbourne in 1994, completed a postgraduate degree in Recombinant DNA Techniques at Monash University (1996) and is undertaking a PhD in Biotechnology in the Biochemical Engineering and Environmental Technology Group at Heriot-Watt University. He has extensive links to industry and academia, was awarded a French Government (Australia-France) Science Fellowship in 2000 and is a member of
First page preview
Click here to open the first page preview
references(274)
- B.SDavidson
Curr. mening. Biotechnology.
(1995)
- TTsukiharaet al.
J. Mol. Biol.
(1990)
- HALuuet al.
Toksikum
(1993)
- RDraget al.
J. Chromatogr., A
(1998)
- KHaradaet al.
Tetrahedron easy.
(1993)
- LShiet al.
J. Biol. Chem.
(1999)
- TTsukudaet al.
Tetrahedron easy.
(1989)
- D.GNagleet al.
Tetrahedron easy.
(1995)
- GRulesbergeret al.
FEMS Microbiol. Lightweight.
(1999)
- PSimonset al.
Tetrahedron easy.
(1992)
Tetrahedron easy.
(1979)
Tetrahedron easy.
(1996)
Tetrahedron easy.
(1999)
Toksikum
(1999)
Tetrahedron easy.
(1979)
Phytochemicals
(1998)
Tetrahedron easy.
(1999)
Tetrahedron easy.
(1996)
Tetrahedron easy.
(1997)
Phytochemicals
(1997)
Tetrahedron easy.
(1979)
Tetrahedron easy.
(1991)
bioorg. With. Chem. Easy.
(1999)
Toksikum
(1989)
Cancer Lett.
(1995)
Phytochemicals
(1978)
life sciences.
(1997)
Biochem. Biophys. Res. Come on.
(2000)
Toksikum
(1995)
J. Ind. Microbiol.
(1996)
Pharmaceutical and bioactive natural products
J. Nat. Prod.
(1997)
J. Org. Chem.
(1995)
J. Org. Chem.
(1998)
J. Phycol.
(1991)
J. Phycol.
(1993)
New medicine from cultivated blue-green algae
Oceanografi
(1996)
A secret world: Natural products from sea life
(1990)
J. Appl. Phykol.
(1994)
J.Ind. Microbiol. Biotechnology.
(1990)
J. Ind. Microbiol.
(1996)
J. Aoac Int.
(1999)
Proximity. health perspective.
(1983)
Gazz. chem. Ital.
(1993)
J. Nat. Prod.
(1990)
J. Phycol.
(1996)
Proximity. Toxicol.
(1999)
Cited by (662)
Culture supernatants of the cyanobacterium Trichormus sp. promote the growth of grass Polypogon australis Brong: role of P and Mn
2023, Algae research
The potential of some soil cyanobacteria to influence plant development through the release of biologically active substances has been extensively characterized. Strategies for this include the use of culture supernatants from cyanobacteria, as these contain compounds that can affect plant development. However, there is little information on how the remaining nutrients from the culture medium used can contribute to the effect observed in the treated plants. In the present work,Tricormussp., a native Chilean cyanobacterium isolated from arid regions, the supernatants of which enhanced cumulative germination, shoot and root growth of the native grassPolypogon australis, was chosen. The observed effects were significant compared to water as a control, but were not significantly different when BG-11 broth was used as a control. The nutritional content ofTricormussp. Supernatants were characterized during the growth phases of the culture on BG-11 medium and showed a marked decrease in P (100%) and Mn content (84%) after the late exponential phase. Based on these results, a P- and Mn-free BG-11 medium (BG-11M) was prepared. In a bioassay withP. australisThe BG-11M effect was compared withTricormussp. Supernatants containing 40% P and 46% Mn compared to the original BG-11 medium. The results showed that BG-11M was less effective in promoting shoot growthP. australisthan the supernatants, suggesting that both elements, P and Mn, play a role in the development ofP. australis. We emphasize the need to consider the composition of the nutrients remaining on the culture medium when evaluating the effects of cyanobacterial cultures on plant growth and development.
Algal-fungal interactions and biomass production in wastewater treatment: current status and future prospects
2023, Algae research
To advance the development of green wastewater biotreatments, an in-depth analysis of algal-fungal interactions and high-quality biomass production is required, as the interactions in these cultures are complex. Microalgae can release a remarkable array of extracellular metabolites, ranging from alkaloids to fatty acids to abundant amino acids and peptides. These metabolites are associated with algicidal, antiprotozoal, insecticidal/larvicidal and antimicrobial activity. Acylhomoserine lactones (AHLs) can regulate the algae-fungi relationship, as they are signaling molecules that significantly influence the metabolism and growth of algae based on the organic matter in their environment. Fungi can use both organic and inorganic nitrogen (N), but are not as efficient as algae; For this reason, the algal-fungal co-culture is better able to remove N from the wastewater than the algal monoculture. Furthermore, the sponge's phosphorus removal capacity is comparable to or even better than algae. Symbiotic algae-fungi systems have a high ability to purify biogas through the use of photosynthesis. In addition, several value-adding substances can be obtained from the biomass of the co-culture, including fatty acids, polysaccharides, triglycerides, pigments and vitamins, which are used as specialty chemicals and bulk goods in various industrial sectors. Fungi can also act as flocculation agents in a way that is harmless to algal biomass, allowing reuse of the culture medium and easier harvesting, further reducing overall costs. Significant increases in biomass and lipid production have been observed in co-cultured algal sponge pellets compared to monoculture. This review aims to discuss hotspots in metabolic research in microalgal-fungal consortia, discuss quorum sensing in these cultures, and describe pioneering applications in wastewater treatment and biomass production technologies. Future prospects for microalgal-fungal consortia in wastewater treatment are also suggested. The results of this review would provide a reference for current research on algal-fungal mechanisms and further large-scale harvesting.
Effect of high-pressure treatment on the shelf life and microbial profile of wild-harvested Ascophyllum nodosum and aquacultured Alaria esculenta during storage
2022, LWT
fresh seaweed,Alaria esculentaAndAscophyllum nodosum,are brown macroalgae species that are considered an excellent source of macro- and micronutrients. It is important to provide new approaches to ensure the microbiological safety of this product to ensure the preservation of nutritional values. In this study, these two species were treated with high pressure as well as traditional preservation methods (dry salt and hot water blanching), followed by a storage process to assess the influence of the microbiological content, and the microbiota profile was investigated after different treatments. High pressure treatments were introduced to avoid salt addition or loss of nutrients associated with traditional algae preservation methods. In general, fresh algae treated at high pressure (500 MPa) still have acceptable total viability values of about 3 log CFU/mL after 30 days when stored at 4°C. 16S rDNA profiling revealed an average of 3059 operational taxonomic units (OTUs) for all algae analyzed. The four dominant phyla were Cyanobacteria, Proteobacteria, Firmicutes and Bacteroidota. Cyanobacteria dominated the bacterial communitiesA. esculentasamples, while Proteobacteria were predominantA. nodosumRehearse. In this study, HPP did not cause significant variation in microbiome profile diversity, but did change the relative abundance of different phyla, including Cyanobacteria, Fermicutes, Bacteriodota and Verrucomicrobia.
Bioprospecting for bioactive compounds in microalgae: antimicrobial compounds
2022, advances in biotechnology
Although there are many ways to use microalgae as antimicrobial agents, little has been done to advance them beyond the characterization phase to the biotechnology phase. A challenge in screening microalgae for antimicrobial activity is their ability to synthesize biologically active secondary metabolites in response to environmental triggers. A rigorous scientific approach is needed to identify potential strains with good antimicrobial activity and promote the development of microalgae as antimicrobial agents. Microalgae are most commonly tested for antimicrobial activity using the disk diffusion test. However, this test is problematic and leads to false positive and false negative results. Quantitative minimum inhibitory concentration (MIC) values determined in assays such as the microdilution broth assay are more reproducible and allow comparison of results between research groups. A dataset of published MIC values for microalgae was compiled for this overview. The cyanobacteria and chlorophyta were most strongly represented, other phyla were underrepresented. These data were used to evaluate factors influencing antimicrobial activity, including test microorganisms, microalgal taxonomy, different extraction solvents, and the growth phase at harvest. Activity was considered good when MIC values were below 1 mg/mL, moderate when MIC values were 1–8 mg/mL, and poor when MIC values were above 8.0 mg/mL. Areas requiring more research will be discussed, including screening a greater diversity of species in appropriate assays, reporting negative results, testing culture supernatant for activity, synergistic effects, and identification of antimicrobial compounds in chlorophyta. The potential for successful development and commercialization of antimicrobial microalgae will increase as more microalgae are studied and compounds are identified.
Therapeutic potential of marine macrolides: A review from 1990 to 2022
2022, Chemical-biological interactions
The ocean is a vast ecosystem that has remained largely unused and unexploited, giving birth to numerous organisms. As a result, marine organisms have attracted the interest of scientists as a rich source of natural resources with unique structural features and exciting biological activities. Marine Macrolide is a premium natural product with a highly oxygenated polyene backbone containing macrocyclic lactone. In recent decades, considerable effort has been made to isolate and characterize the chemical and biological properties of macrolides. Numerous macrolides are derived from various marine organisms such as marine microorganisms, fungi, zooplankton, molluscs, cnidarians, red algae, marsupials and bryozoans. In particular, the most important sources of macrolides are fungi, dinoflagellates and fungi. Marine macrolides have several bioactive properties such as antimicrobial (antibacterial, antifungal, antimalarial, antiviral), anti-inflammatory, antidiabetic, cytotoxic and neuroprotective effects. In short, marine organisms are abundant in naturally occurring macrolides, which can become the source of effective and efficient therapies for many diseases. This recent review summarizes these exciting and promising new marine macrolides in terms of biological activities and potential therapeutic applications.
Metabolic composition of the cyanobacterium Nostoc muscorum as a function of cultivation time: a1H-NMR-Metabolomics-studie
2022, Algae research
Cyanobacteria are considered a factory for value-added substances. However, knowledge of the many interesting compounds that can be obtained from these prokaryotic organisms is still very limited. Nuclear magnetic resonance (NMR) spectroscopy is a widely used metabolic profiling technique that provides an overview of the most important metabolites in complex biological matrices. In this work high resoln1H NMR was used to study the metabolic composition of freshwater cyanobacteriaFrom the bogs. This species showed high longevity and could grow for more than a hundred days without medium supplementation. Several interesting metabolites were detected during the study period, including several sugars and oligosaccharides, lipids (z.B., glycolipids, ω-3 and ω-6 fatty acids), amino acids, including mycosporin-like, peptides and pigments (z.B., ChlorophyllINand carotenoids). Thanks to the long-term monitoring implemented in this study, the production of these compounds can be linked to specific growth momentsnumber of fliesThis provides new insight into the most suitable harvest times for biotechnological use of certain molecules.
Selected articles (6)
Research Article
The cyanobacterial lectin scytovirin shows potent in vitro and in vivo activity against Zaire Ebola virus
Antiviral Research, bind 112, 2014, s. 1-7
The cyanobacterial lectin scytovirin (SVN) binds with high affinity to high-mannose oligosaccharides on the envelope glycoprotein (GP) of a number of viruses and thereby blocks access to target cells. In this study, we investigated the ability of SVN to bind to Zaire ebola virus (ZEBOV) envelope GP and inhibit replication. SVN specifically interacted with the mucin-rich domain of the protein. In cell culture, it inhibited ZEBOV replication at a virus inhibitory concentration of 50% (EC50) at 50 nM and was also active against the Angola strain of the related Marburg virus (MARV) with a similar EC50. Injected subcutaneously into mice, SVN reached a peak plasma level of 100 nM in 45 min but was cleared within 4 h. When ZEBOV-infected mice received SVN by subcutaneous injection at 30 mg/kg/day every 6 hours starting the day before virus challenge, 9 out of 10 animals survived the infection, whereas all infected, untreated mice died. When treatment started one hour or one day after challenge, 70-90% of the mice survived. Quantification of infectious virus and viral RNA in serum, liver, and spleen samples taken on days 2 and 5 post-infection showed a trend toward lower titers in treated mice than in control mice, with a significant decrease in liver titers on the second day. Our findings provide further evidence for the potential of natural lectins as therapeutic agents in viral infections.
Research Article
Almiramide D, a cytotoxic peptide from the marine cyanobacterium Oscillatoria nigroviridis
Bioorganic & Medicinal Chemistry, Band 22, Ausgabe 24, 2014, S. 6789-6795
Marine benthic cyanobacteria are well known as a source of toxic and potentially beneficial compounds. These microorganisms have been studied at many Caribbean sites, including recently sites in the Colombian Caribbean Sea. In this study, six lipopeptides named Almiramide D to H along with the well-known Almiramide B are identified from a mat labeled asOscillatoria nigroviridiscollected on Providence Island (Colombia, southwestern Caribbean Sea). The most abundant compounds, almiramides B and D, were characterized by NMR and HRESIMS, while the structures of the minor compounds, almiramides E to H, were suggested by analysis of their HRESIMS and MS2spectra. Almiramide B and D were tested against six human cell lines, including a gingival fibroblast cell line and five human tumor cell lines (A549, MDA-MB231, MCF-7, HeLa and PC3), which showed potent but non-selective toxicity.
Research Article
Kalkipyrone B, a marine cyanobacterial γ-pyrone with cytotoxic and antifungal activities
Phytochemie, Band 122, 2016, S. 113-118
Bioassay-guided fractionation of two marine cyanobacterial extracts using human lung cancer cell line H-460 and human ovarian cancer cell line OVC-5 led to the isolation of three related α-methoxy-B,B′-dimethyl-γ-pyrones, each containing a modified alkyl chain, one of which has been identified as the previously described calcipyrone and designated calcipyrone A. The other compound was an analog named calcipyrone B. The third compound was identified as the recently reported yoshinone A. also isolated from a marine cyanobacterium. Calcipyrone A and B were obtained from a field collection of cyanobacteriaLeptolyngbyasp. from Fagasa Bay, American Samoa, while Yoshinon A was isolated from a field collection of cyanobacteria (cf.Schizotrixsp.) from Panama. One-dimensional and two-dimensional NMR experiments were used to determine the overall structures and relative configurations of the calkypyrones, and the absolute configuration of calkypyrone B was determined1H NMR Analysis of Diastereomeric Mosher Esters. Calcipyrone A showed good cytotoxicity against H-460 human lung cancer cells (EC50= 0.9 μM), while calkipyrone B and yoshinone A were less active (EC50=9.0μM or >10μM). Both Kalkipyrone A and B showed moderate toxicitySaccharomyces cerevisiaeABC16-Monster-Stamm (IC50= 14.6 and 13.4 μM, respectively), whereas Yoshinon A showed low toxicity to this yeast strain (IC50=63,8μM).
Research Article
Antioxidant activity of the phycocyanin pigment extracted from marine filamentous cyanobacteria Geitlerinema sp TRV57
Biocatalysis and Agricultural Biotechnology, bind 16, 2018, side 237-242
Phycocyanin is a blue-colored, naturally occurring phycobiliprotein pigment that is abundant in cyanobacteria, a blue-green algae. In this study, phycocyanin was derived fromGeitlerinemasp. TRV57. The extracted pigment was analyzed for its antioxidant properties using various methods, e.g. B. Phosphomolybdenum test, iron ion reduction performance test, DPPH radical scavenging activity, hydrogen peroxide radical scavenging test and anti-lipid peroxidation activity. These tests showed significant antioxidant activity of phycocyanin. At a concentration of 200 µg/ml, phycocyanin showed a maximum absorbance of 0.49 in the phosphomolybdenum assay, an absorbance of 0.85 in the ferric ion reduction test, 78.75% of DPPH scavenging activity, and 95.27% of H.2Ö2cleanup activity. IC50A phycocyanin value of 185 µg/ml was determined for the anti-lipid peroxidation test. The study shows that the phycocyanin pigments have antioxidant properties and can be used as a promising pharmaceutical and nutraceutical compound.
Research Article
Properties of cyanobacterial lectins and their role as antiviral agents
International Journal of Biological Macromolecules, Bånd 102, 2017, S. 475-496
Lectins are ubiquitous proteins/glycoproteins of non-immune origin that bind reversibly to carbohydrates in a non-covalent and highly specific manner. These lectin-glycan interactions could be exploited to establish new therapeutic agents that target the adherence stage of viruses and thus help eliminate widespread viral infections. Here, the review focuses on hemagglutination activity, carbohydrate specificity and properties of cyanobacterial lectins. Cyanobacterial lectins, which exhibit high specificity towards mannose or complex glycans, may play a role as antiviral agents. The possible role of cyanobacterial lectins in combating various diseases of global concern, such as HIV, hepatitis, herpes, influenza and Ebola virus, has been widely discussed. The review also focuses on recent studies dealing with the structural analysis of glycan-lectin interactions, which in turn influence their mechanism of action. Overall, the promising approach of these cyanobacterial lectins provides insight into their use as antiviral agents.
Research Article
Biotechnological use of cyanobacteria and microalgae for bioactive compounds
Biotechnological production of bioactive compounds, 2020, pp. 221-259
As the main components of phytoplankton, microalgae and cyanobacteria are central to the global food chain and essential for the maintenance of Earth's ecosystems. Due to their adaptability to different cell culture conditions, algae are extremely versatile and therefore produce a wide range of valuable bioactive compounds. In recent decades, attention has increasingly been paid to the possibilities of commercial algae cultivation. Bioactive algal compounds include antioxidants (polyphenols, tocopherols, vitamin C, mycosporin-like amino acids), peptides (cyclic and acyclic), polyunsaturated fatty acids (PUFA) (e.g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)) e.g. β-glucan) and pigments such as carotenoids (carotene xanthophyll), chlorophylls and phycobilins (phycocyanin, phycoerythrin), etc. showed antibacterial, antiviral, antifungal, antioxidant, anti-inflammatory and antitumor properties. New cultivation and extraction techniques are effective in cultivating algal biomass and converting it into extracts of biologically active compounds without degradation. This chapter provides an overview of the biologically active compounds derived from algal biomass and their potential role in human well-being in a structured manner.
Adam M. Burjareceived his Bachelor of Science from the University of Melbourne in 1994, completed a postgraduate degree in Recombinant DNA Techniques at Monash University (1996) and is undertaking a PhD in Biotechnology in the Biochemical Engineering and Environmental Technology Group at Heriot-Watt University. He has extensive links to industry and academia, having received a French Government (Australia-France) Science Fellowship in 2000 and is a member of the EU's COST Action for Hydrogen Production. His current research interests focus on the effects of stress on marine microorganisms and natural product production, the use of molecular biology techniques within microbial communities to produce targeted compounds, hydrogen production using microalgae, bioprocess intensification and bioreactor design, and marine research Natural Products Microbial Physiology.
Bernard Banaigsreceived his doctorate in philosophy from the University of Montpellier, France, in 1983. After completing his doctorate in natural product chemistry, he held several postdoctoral positions at internationally recognized institutes, including the Scripps Institution of Oceanography. In 1986 he joined the Center de Phytopharmacie at the University of Perpignan as a research assistant and is currently a research assistant at the Institut National de la Santé et de la recherché médicale. He has close industrial ties to several pharmaceutical companies and is a member of the editorial board of the international journal Marine Biotechnology. He has published numerous articles and is a regular reviewer for the journals Botanica Marina and Marine Biotechnology.
Eliane Abou-Mansouris a native of Lebanon, where she received her BSc in Chemistry from the Lebanese University of Beirut in 1986. She taught chemistry and physics at a secondary school in Beirut for four years before moving to France, where she received her Ph.D. in Chemistry of Marine Natural Products in 1994 from the University of Perpignan. In 1996 she joined the Australian Institute of Marine Science as a post-doctoral researcher working on the chemical properties of natural products from marine microbes. After returning to the University of Perpignan in 1999, she worked on isolating bioactive compounds from marine cyanobacteria. She joined the Institute of Chemistry in Neuchâtel (Switzerland) in 2000 as a research associate to work on the identification of fungal phycotoxins within the framework of the Swiss role of national research for plant survival and the EU's COST Action 835 on Plant Diseases, which is involved in stem and wine diseases.
J. Grant Burgessreceived his Bachelor of Science (Honours) from Queen Elizabeth College, University of London in 1986 and his PhD from Imperial College London in 1989. After completing his PhD, he accepted a postdoctoral fellowship at Tokyo University of Agriculture. Between 1990 and 1993, he worked as an assistant professor of marine microbiology and biotechnology at Tokyo University of Agriculture and Technology. He joined Heriot-Watt University as an Associate Professor in 1994 and was promoted to Reader in Marine Biotechnology in 1999. His research interests include industrial and medical applications of marine bacteria and fungi.
Philip C. Wrightreceived his Bachelor of Engineering from the University of New South Wales in 1991, completed a Research Master of Engineering at the University of Wollongong in 1993 and received his PhD in 1997 under the supervision of Professor Judy Raper. After completing his Ph.D. he accepted the post of Associate Professor of Chemical Engineering at Heriot-Watt University (1997), was recently promoted to Reader and is co-founder of the Biochemical Engineering and Environmental Technologies Group. He collaborates with industry and academia, is co-chair of the EPSRC Marine Bioprocess Engineering Network, receives an EPSRC Advanced Research Fellowship and is a member of the EU's COST Action for Hydrogen Production. His current research interests include multiphase reactor processes, bioprocess intensification, metabolic engineering, and protein control and characterization.
Copyright © 2001 Elsevier Science Ltd. All rights reserved.